Read + Share
Amedeo Smart
Independent Medical Education
Lim M, Franses JW, Imperial R, Majeed U, et al. EGFR/ERBB2 amplifications and alterations associated with resistance to lenvatinib in hepatocellular carcinoma. Gastroenterology 2023 Jan 25:S0016-5085(23)00056.PMID: 36708791
Email
LinkedIn
Facebook
Twitter
Privacy Policy